FIRM FIXED PRICESMALL BUSINESS SET ASIDE - PARTIAL

GENSCRIPT USA INC - MONOCLONAL ANTIBODY PRODUCTION

PIID: 75F40120P00404
Signed Date: Jan 26, 2026Effective Date: Jul 21, 2020End Date: Closed on Jul 31, 2021
Award $
$21K
Vendor
GENSCRIPT USA INC
NAICS
325414
Signed Date
Jan 26, 2026

Key Details

Dollars Obligated
$20,745.32
Base & All Options
$-0.14
Awarding Sub-Agency
Food and Drug Administration
Product Service Code
B504 - SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL
Extent Competed
COMPETED UNDER SAP
Number of Offers
2
Place of Performance
PISCATAWAY, NJ, 088543918, CD-NJ-06

Description

MONOCLONAL ANTIBODY PRODUCTION

Context & Analysis

On Jan 26, 2026, Department of Health and Human Services obligated $20,745.32 to GENSCRIPT USA INC for monoclonal antibody production. The award is classified under NAICS 325414 — BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING and issued as a firm fixed price contract. Competition extent: competed under sap with 2 offers received. The procurement used a SMALL BUSINESS SET ASIDE - PARTIAL set-aside. Performance is located in PISCATAWAY, NJ.

Contractor Information

Contractor: GENSCRIPT USA INC
UEI: KVLBRRAQ6UX1
CAGE Code: 5THB5
Location: PISCATAWAY, NJ
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related